NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Joshua Sabari Md
New York University - New York / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4688201
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Joshua Sabari Md's MOST POPULAR ARTICLES
1-)
Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registryJ Mazieres, A Drilon, A Lusque, L Mhanna, AB Cortot, L Mezquita, ...Annals of Oncology 30 (8), 1321-1328, 20197312019
2-)
Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non-small-cell lung cancerKC Arbour, L Mezquita, N Long, H Rizvi, E Auclin, A Ni, G Martínez-Bernal, ...J Clin Oncol 36 (28), 2872-2878, 20187122018
3-)
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C MutationPA Jänne, GJ Riely, SM Gadgeel, RS Heist, SHI Ou, JM Pacheco, ...New England Journal of Medicine 387 (2), 120-131, 20224942022
4-)
Amivantamab in EGFR exon 20 insertion–mutated non–small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I studyK Park, EB Haura, NB Leighl, P Mitchell, CA Shu, N Girard, S Viteri, ...Journal of Clinical Oncology 39 (30), 3391-3402, 20215242021
5-)
Unravelling the biology of SCLC: implications for therapyJK Sabari, BH Lok, JH Laird, JT Poirier, CM RudinNature reviews Clinical oncology 14 (9), 549-561, 20174652017
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept